Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07077707 · ClinicalTrials.gov registry record · NA
Prenatal Genetics Chatbot Trial: Prenatal GENEie
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Not yet
- Registry status
- NA
- Development phase
- 1,470
- Enrollment target
NCT07077707: Clinical Trial NA study, sponsored by Women and Infants Hospital of Rhode Island.
NCT07077707 is a NA study that has not yet begun recruiting, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 1,470 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07077707, a NA study, has not yet begun recruiting, sponsored by Women and Infants Hospital of Rhode Island.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,470 participants
- Enrollment target
Study Summary
During pregnancy, all pregnant people are offered tests to look for genetic conditions in the baby. However, there isn't a standard way of giving this information to patients. Doctors have a lot of things to discuss during the first prenatal visit and don't always have time to explain genetics in detail. Also, not everyone has access to genetic counselors. Prenatal genetics can be confusing, especially for people who haven't had a lot of formal education or who speak languages other than English. There might be misunderstandings about what these tests can find and what their benefits or risks are for these tests. Mobile apps, like chatbots, could be a helpful way to give information about prenatal genetics. Almost everyone has a cell phone, and a chatbot can let people learn at their own speed and whenever they want. The goal of this study is to see if a chatbot app Prenatal GENEie can teach pregnant women about prenatal genetics, and compare the chatbot to talking with a genetic counselor in person. The study wants to answer these main questions: * Does the Prenatal GENEie help pregnant patients learn about prenatal genetics the same way as a meeting with a genetic counselor? * Can the Prenatal GENEie and in-person counseling both help people make decisions about whether they want prenatal genetic testing? The researchers will compare the chatbot Prenatal GENEie with in-person counseling to see if the chatbot teaches people about prenatal genetics in a similar way. Participants will: * Take a test to check what they already know about prenatal genetics prior to the intervention * Use the chatbot or have an in-person meeting with a genetic counselor * Take a test after using the chatbot or meeting with a counselor to see how much their knowledge has improved * Fill out a survey about how comfortable they feel with their decision to do or not do prenatal genetic testing
Primary Outcome
The prenatal knowledge score is calculated from questionnaire with 30 true/false questions. The scores range from 0 (lowest knowledge) to 30 (highest knowledge), reflecting the number of correct responses.. The change in prenatal knowledge score is then calculated from the percent answered correctly after the intervention from number of correct responses before the intervention. The highest knowledge increase is 30 and the lowest is 0.
Interventions
- OTHER Prenatal GENEie Chatbot
- OTHER In-person genetic counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,470 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
What is known before NCT07077707 opens enrollment
NCT07077707 is an interventional study that assigns participants to a tested intervention. Its 1,470 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Prenatal GENEie Chatbot is the first listed.
NCT07077707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07077707 about?
NCT07077707 is a clinical study titled "Prenatal Genetics Chatbot Trial: Prenatal GENEie". During pregnancy, all pregnant people are offered tests to look for genetic conditions in the baby. However, there isn't a standard way of giving this information to patients. Doctors have a lot of things to discuss during the first prenatal visit and don't always have time to explain genetics in de...
What is the current status of trial NCT07077707?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,470 participants. The study started on 2026-01-01. Estimated completion is 2029-03-31.
What interventions are being tested in trial NCT07077707?
The interventions under investigation include: Prenatal GENEie Chatbot (OTHER), In-person genetic counseling (OTHER).
Who is sponsoring clinical trial NCT07077707?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07077707's enrollment target sits among peer trials
1,470 68th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI